This is a Validated Antibody Database (VAD) review about rabbit ACTA2, based on 67 published articles (read how Labome selects the articles), using ACTA2 antibody in all methods. It is aimed to help Labome visitors find the most suited ACTA2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ACTA2 synonym: actin, aortic smooth muscle; alpha-actin-2; alpha-smooth muscle actin

Invitrogen
mouse monoclonal (1A4 (asm-1))
  • immunohistochemistry - frozen section; mouse; loading ...; fig 3a
Invitrogen ACTA2 antibody (Thermofisher, MS-113-P) was used in immunohistochemistry - frozen section on mouse samples (fig 3a). Cell Death Dis (2018) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:50; loading ...; fig 2d
Invitrogen ACTA2 antibody (Thermo, MA5-11869) was used in western blot on human samples at 1:50 (fig 2d). Nat Commun (2018) ncbi
mouse monoclonal (1A4 (asm-1))
  • immunohistochemistry; mouse; loading ...; fig 6b
  • western blot; mouse; loading ...; fig 8d
In order to study the role of beta actin in chromatin organization and cellular identity, Invitrogen ACTA2 antibody (Thermo Fisher, MA5-11547) was used in immunohistochemistry on mouse samples (fig 6b) and in western blot on mouse samples (fig 8d). FASEB J (2018) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:1000; loading ...; fig 2e
In order to study the involvement of RNase III nucleases in antiviral systems, Invitrogen ACTA2 antibody (Thermo Fisher, MS-1295-P) was used in western blot on human samples at 1:1000 (fig 2e). Nature (2017) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry; human; loading ...; fig 11a
In order to investigate the tumor microenvironment in tertiary lymphoid organs of prostate cancer patients, Invitrogen ACTA2 antibody (Thermo Fisher Scientific, 1A4) was used in immunohistochemistry on human samples (fig 11a). Front Immunol (2017) ncbi
mouse monoclonal (1A4 (asm-1))
  • immunocytochemistry; human; loading ...; fig 3
In order to describe a "Ring Stacking Method" to synthesize blood vessels, Invitrogen ACTA2 antibody (Thermo Fisher Scientific, MA5-11547) was used in immunocytochemistry on human samples (fig 3). J Vis Exp (2017) ncbi
mouse monoclonal (5C5.F8.C7 (alpha-Sr-1))
  • immunocytochemistry; mouse; 1:500; loading ...; fig s1c
  • western blot; mouse; 1:2500; loading ...; fig 3a
In order to clarify how actin isoforms modulate the axons of developing motoneurons, Invitrogen ACTA2 antibody (Thermo Fisher Scientific, MA5-12542) was used in immunocytochemistry on mouse samples at 1:500 (fig s1c) and in western blot on mouse samples at 1:2500 (fig 3a). J Cell Biol (2017) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; baker's yeast; fig 2c
In order to report that Lpl1 as a target of the Rpn4 response, Invitrogen ACTA2 antibody (ThermoFisher, MA511866) was used in western blot on baker's yeast samples (fig 2c). Mol Biol Cell (2017) ncbi
mouse monoclonal (1A4)
  • western blot; human; fig 3e
In order to test if exogenous transfer of unphosphorylated phosphatase and tensin homologue deleted from chromosome 10 leads to reduce transforming growth factor beta-induced extracellular matrix expression in both epithelial cells and fibroblasts, Invitrogen ACTA2 antibody (Lab Vision, 1A4) was used in western blot on human samples (fig 3e). Wound Repair Regen (2017) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; zebrafish ; 1:5000; loading ...; fig s2e
In order to propose that neurodevelopmental disorders and brain tumors may arise from changes in oncogenes, Invitrogen ACTA2 antibody (Neomarkers, ACTN05) was used in western blot on zebrafish samples at 1:5000 (fig s2e). Dis Model Mech (2017) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 1b
In order to examine the vascular alterations in the areas of parenchymal extinction, Invitrogen ACTA2 antibody (Thermo, PA5-16697) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1b). J Hepatol (2017) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:100; loading ...; fig 1b
In order to find that TrpC5 regulates differentiation in colorectal cancer, Invitrogen ACTA2 antibody (Invitrogen, MA5-11869) was used in western blot on human samples at 1:100 (fig 1b). Clin Sci (Lond) (2017) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; loading ...; fig 5g
In order to investigate the alternative splicing of E-cadherin mRNA, Invitrogen ACTA2 antibody (Neomarkers, ACTN05) was used in western blot on human samples (fig 5g). J Cell Physiol (2017) ncbi
mouse monoclonal (1A4 (asm-1))
  • immunohistochemistry - paraffin section; mouse; 1:600; loading ...; fig 5a
In order to examine the liver regeneration process after physical partial hepatectomy, Invitrogen ACTA2 antibody (Thermo Scientific, MS-113-P) was used in immunohistochemistry - paraffin section on mouse samples at 1:600 (fig 5a). Lab Invest (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:300; fig 2
In order to study CD133+ subpopulations in pancreatic cancer, Invitrogen ACTA2 antibody (Thermo Fisher Scientific, Ab-5) was used in western blot on human samples at 1:300 (fig 2). Oncol Lett (2016) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3b
In order to characterize alterations in fibroblast populations in the skin of patients with systemic sclerosis, Invitrogen ACTA2 antibody (Thermo Scientific, 1A4) was used in immunohistochemistry - paraffin section on human samples (fig 3b). Am J Pathol (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; fig 1
In order to study how PARylation regulates Top1 nuclear dynamics, Invitrogen ACTA2 antibody (Neo Markers, ACTN05) was used in western blot on human samples (fig 1). Nucleic Acids Res (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse; fig 3b
In order to screen for deubiquitinase inhibitors that prevent infection of macrophages by intracellular pathogens, Invitrogen ACTA2 antibody (Thermo Scientific, ACTN05) was used in western blot on mouse samples (fig 3b). Antimicrob Agents Chemother (2016) ncbi
mouse monoclonal (HHF35)
  • immunohistochemistry - paraffin section; rabbit; 1:4; fig 1
In order to study the evidence of CD34/SMA positive cells in atherogenesis in left main coronary artery, Invitrogen ACTA2 antibody (ThermoFisher Scientific, MA5-14084) was used in immunohistochemistry - paraffin section on rabbit samples at 1:4 (fig 1). Acta Histochem (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse; 1:3000; fig 1
  • western blot; human; 1:3000; fig 3
In order to investigate the PTHrP-cAMP-CREB1 axis in osteosarcoma, Invitrogen ACTA2 antibody (Thermo Scientific, Ab-5) was used in western blot on mouse samples at 1:3000 (fig 1) and in western blot on human samples at 1:3000 (fig 3). elife (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; fig 1
In order to study attenuation of AKT signaling to promote internal ribosome entry site-dependent translation and expression of c-MYC by the human papillomavirus 16 E7 oncoprotein, Invitrogen ACTA2 antibody (Thermo Scientific, MS-1295-P1) was used in western blot on human samples (fig 1). J Virol (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; dog; fig 8
In order to study how the role of increased caveolin-1 can help with repair to intervertebral disc degeneration, Invitrogen ACTA2 antibody (Neomarkers, pan Ab-5) was used in western blot on dog samples (fig 8). Arthritis Res Ther (2016) ncbi
mouse monoclonal (1A4 (asm-1))
  • immunohistochemistry - paraffin section; human; fig 2
In order to study human lacrimal epithelium and histatin-1 expression, Invitrogen ACTA2 antibody (Thermo Scientific, MS-113-P0) was used in immunohistochemistry - paraffin section on human samples (fig 2). PLoS ONE (2016) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - paraffin section; human; fig 2
In order to study human lacrimal epithelium and histatin-1 expression, Invitrogen ACTA2 antibody (Thermo Scientific, MS-113-P0) was used in immunohistochemistry - paraffin section on human samples (fig 2). PLoS ONE (2016) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:10,000; fig 3
In order to investigate how redox reactions affect treatment of chronic lymphocytic leukemia, Invitrogen ACTA2 antibody (Pierce Biotechnology, MA5-11869) was used in western blot on human samples at 1:10,000 (fig 3). Mol Med Rep (2015) ncbi
rabbit polyclonal
  • western blot; mouse; 1:500; fig s4
In order to learn about disruption of vascular wall structure and function by smooth muscle-targeted overexpression of peroxisome proliferator activated receptor-gamma, Invitrogen ACTA2 antibody (Thermo Fisher, RB-9010-P) was used in western blot on mouse samples at 1:500 (fig s4). PLoS ONE (2015) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry; human; 1:1000; fig 6
In order to present two cases of primary sclerosing epithelioid fibrosarcoma of the kidney, Invitrogen ACTA2 antibody (NeoMarkers, 1A4) was used in immunohistochemistry on human samples at 1:1000 (fig 6). Diagn Pathol (2015) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; fig 2a
In order to study platelet CLEC-2 and vascular smooth muscle cells that stimulate platelets and facilitate thrombus formation and implications in atherothrombosis, Invitrogen ACTA2 antibody (Thermo Scientific, RB-9010-P0) was used in immunohistochemistry - frozen section on mouse samples (fig 2a). PLoS ONE (2015) ncbi
mouse monoclonal (1A4 (asm-1))
  • immunohistochemistry; cow; 1:100; fig 6
In order to analyze PiggyBac transposition of doxycycline-inducible transcription factors due to generation of niave bovine induced pluripotent stem cells, Invitrogen ACTA2 antibody (Thermo, MS-113-P0) was used in immunohistochemistry on cow samples at 1:100 (fig 6). PLoS ONE (2015) ncbi
rabbit polyclonal
  • western blot; mouse; 1:500
In order to elucidate the potential of PIK3CA to induce multipotency during tumorigenesis in the mammary gland, Invitrogen ACTA2 antibody (Thermo Scientific, Rb9010) was used in western blot on mouse samples at 1:500. Nature (2015) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human
In order to study the role of ADAM17 in cellular senescence and senescence secretome, Invitrogen ACTA2 antibody (Thermo Scientific, MA5-11869) was used in western blot on human samples . Breast Cancer Res (2015) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; fruit fly; 1:4000; fig 9
In order to suggest that CDK8-CycC links nutrient intake to EcR activity and Drosophila development, Invitrogen ACTA2 antibody (Thermo Scientific, MA5-11869)) was used in western blot on fruit fly samples at 1:4000 (fig 9). PLoS Biol (2015) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse; 1:500; fig 5a
In order to assess the anti-fatigue effects of Myelophil, Invitrogen ACTA2 antibody (Thermo Fisher, MA5-11869) was used in western blot on mouse samples at 1:500 (fig 5a). Eur J Pharmacol (2015) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human
In order to discuss using serum CSE1L as a biomarker for assessing the efficacy of cancer therapy, Invitrogen ACTA2 antibody (Lab Vision, Ab-5) was used in western blot on human samples . J Transl Med (2015) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - paraffin section; rat; 1:5000
In order to study the epithelial and stromal alterations in prostate following cypermethrin administration in adult albino rats, Invitrogen ACTA2 antibody (Lab Vision Corporation, alpha-Actin) was used in immunohistochemistry - paraffin section on rat samples at 1:5000. Tissue Cell (2015) ncbi
mouse monoclonal (0.N.5)
  • western blot; human
In order to study the role of Src homology phosphotyrosyl phosphatase 2 (SHP2) in triple negative breast cancers, Invitrogen ACTA2 antibody (Thermo Scientific, MA1-26017) was used in western blot on human samples . BMC Cancer (2015) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse; 1:500
In order to evaluate the anti-fatigue effects of Gongjin-Dan in a chronic forced exercise mouse model, Invitrogen ACTA2 antibody (Thermo Fisher, MA5-11869) was used in western blot on mouse samples at 1:500. J Ethnopharmacol (2015) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse
In order to evaluate the protective effect of dietary cis9, trans11 conjugated linoleic acid on gliadin-induced enteropathy, Invitrogen ACTA2 antibody (Thermo Scientific, ACTN05) was used in western blot on mouse samples . Eur J Nutr (2016) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - paraffin section; human; 1:300
In order to identify and characterize vessels that encapsulated tumor clusters in hepatocellular carcinoma sections, Invitrogen ACTA2 antibody (Life Technologies, 1A4) was used in immunohistochemistry - paraffin section on human samples at 1:300. Hepatology (2015) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - paraffin section; rat; 1:200
In order to investigate the role of cannabinoid receptor type 2 (CB2R) during skeletal muscle regeneration, Invitrogen ACTA2 antibody (Lab Vision, MS-113) was used in immunohistochemistry - paraffin section on rat samples at 1:200. Histol Histopathol (2015) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; 1:10,000; fig 5
In order to show that sustained Zeb2 expression initiates T-cell leukemia, Invitrogen ACTA2 antibody (Molecular probes, C4) was used in western blot on human samples at 1:10,000 (fig 5). Nat Commun (2015) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse; fig 1,2,3,4,5,6
In order to determine the role of progesterone receptor activation in increasing protein turnover and downregulation of GATA3 transcriptional repression which promotes breast tumor growth, Invitrogen ACTA2 antibody (neomarkers, ACTN05) was used in western blot on mouse samples (fig 1,2,3,4,5,6). Breast Cancer Res (2014) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human
In order to examine the effects of miR-23a in cell death, Invitrogen ACTA2 antibody (NeoMarkers, ACTN05) was used in western blot on human samples . Cell Death Dis (2014) ncbi
mouse monoclonal (1A4)
In order to examine the adverse effect of prostaglandin F-receptor antagonist AS604872 on brain vasculature, Invitrogen ACTA2 antibody (Thermo Scientific, MS113) was used . J Pharmacol Sci (2014) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry; human; 1:600
In order to identify tissue origin of the granular cell tumor using immunohistochemistry, Invitrogen ACTA2 antibody (LabVision, 1A4) was used in immunohistochemistry on human samples at 1:600. Arch Dermatol Res (2015) ncbi
mouse monoclonal (1A4 (asm-1))
  • immunohistochemistry - frozen section; mouse; 1:100; fig 1
In order to characterize PDGF-mediated skeletal muscle angiogenesis and the role of CD248 (Endosialin), Invitrogen ACTA2 antibody (NeoMarkers, 1A4) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1). PLoS ONE (2014) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 1
In order to characterize PDGF-mediated skeletal muscle angiogenesis and the role of CD248 (Endosialin), Invitrogen ACTA2 antibody (NeoMarkers, 1A4) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1). PLoS ONE (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; fig 4
In order to analyze promotion of a differentiated tumor cell phenotype and inhibition of pancreatic cancer metastasis by neutralizing murine TGF-betaR2, Invitrogen ACTA2 antibody (NeoMarkers, RB9010-P) was used in immunohistochemistry - paraffin section on human samples (fig 4). Cancer Res (2014) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; fruit fly; 1:4000
In order to study the role of Histone lysine demethylase 2 (KDM2) in Drosophila development, Invitrogen ACTA2 antibody (Thermo Scientific, MA5-11869) was used in western blot on fruit fly samples at 1:4000. Mech Dev (2014) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; dog; 1:2000
In order to analyze divergent LEF1 expression in ligand-independent canonical Wnt activity in canine mammary tumor cell lines, Invitrogen ACTA2 antibody (Thermo, MS-1295-P1) was used in western blot on dog samples at 1:2000. PLoS ONE (2014) ncbi
mouse monoclonal (ACTN05 (C4))
In order to investigate the role of Wdr1 in actin dynamics, Invitrogen ACTA2 antibody (Thermo Fisher Scientific, MS-1295-P1ABX) was used . Am J Pathol (2014) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - paraffin section; human
In order to characterize stroma cells and ductal epithelium comparing chronic pancreatitis and pancreatic ductal adenocarcinoma, Invitrogen ACTA2 antibody (Fisher/Thermo Scientific, 1A4) was used in immunohistochemistry - paraffin section on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse; 1:1000; fig 5
In order to investigate the relationship between vitamin D and parathyroid hormone signaling during skeletal development, Invitrogen ACTA2 antibody (NeoMarkers, MS-1295-P1) was used in western blot on mouse samples at 1:1000 (fig 5). J Cell Physiol (2014) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse; fig 1
In order to investigate the role of caspase-2 in programed cell death during infection with Brucella abortus, Invitrogen ACTA2 antibody (Thermo Scientific, MS1295P1) was used in western blot on mouse samples (fig 1). Front Cell Infect Microbiol (2013) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse
In order to test if enterically targeted rapamycin prevents neoplasia and extends survival of cancer prone Apc(Min/+) mice, Invitrogen ACTA2 antibody (Thermo Fisher, ACTN05) was used in western blot on mouse samples . Cancer Prev Res (Phila) (2014) ncbi
mouse monoclonal (HHF35)
  • immunohistochemistry; human; 1:100; tbl 1
In order to report on a case of plexiform fibromyxoma of the stomach, Invitrogen ACTA2 antibody (Neomarker, HHF-35) was used in immunohistochemistry on human samples at 1:100 (tbl 1). Int J Surg Pathol (2014) ncbi
mouse monoclonal (1A4 (asm-1))
  • immunohistochemistry; human; 1:100; tbl 1
In order to report on a case of plexiform fibromyxoma of the stomach, Invitrogen ACTA2 antibody (Invitrogen, IA4) was used in immunohistochemistry on human samples at 1:100 (tbl 1). Int J Surg Pathol (2014) ncbi
mouse monoclonal (1A4 (asm-1))
  • immunocytochemistry; human; 1:100; loading ...; fig 7a
In order to describe methods to isolate and evaluate multilineage-differentiating stress-enduring cells, Invitrogen ACTA2 antibody (LabVision, MS-113-P0) was used in immunocytochemistry on human samples at 1:100 (fig 7a). Nat Protoc (2013) ncbi
rabbit polyclonal
  • immunohistochemistry - frozen section; rat; 1:200; loading ...; fig 7
  • immunocytochemistry; rat; 1:200; loading ...; fig 1b
In order to discuss factors that contribute to defects observed in diabetic bladders, Invitrogen ACTA2 antibody (Thermo Fisher Scientific, RB-9010) was used in immunohistochemistry - frozen section on rat samples at 1:200 (fig 7) and in immunocytochemistry on rat samples at 1:200 (fig 1b). Cytotherapy (2013) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry; mouse
In order to study the induction of inflammation, metaplasia and displasia following transgenic expression of IFN-gamma in the murine stomach, Invitrogen ACTA2 antibody (NeoMarkers, MS-113-P0) was used in immunohistochemistry on mouse samples . Am J Pathol (2012) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:500; fig 1
In order to elucidate the contribution of PIK3CA H1047R to breast cancer pathogenesis, Invitrogen ACTA2 antibody (Thermo, RB-9010) was used in immunohistochemistry on mouse samples at 1:500 (fig 1). Cancer Res (2011) ncbi
mouse monoclonal (1A4 (asm-1))
  • immunohistochemistry - paraffin section; human; 1:1000; fig 2, 3, 4
In order to report a new clinical case of prostatic adenomas with abnormal p63 expression, Invitrogen ACTA2 antibody (NeoMarkers, IA4) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2, 3, 4). Int J Surg Pathol (2011) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; fig 3
In order to report that CSE1L regulates the association of alpha-tubulin with beta-tubulin and promotes migration of MCF-7 breast cancer cells, Invitrogen ACTA2 antibody (Lab Vision, Ab-5) was used in western blot on human samples (fig 3). Exp Cell Res (2010) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; mouse; fig 6
In order to characterize a mouse model of endocrine-resistant breast cancer, Invitrogen ACTA2 antibody (Neomarkers, ACTN05) was used in western blot on mouse samples (fig 6). PLoS ONE (2010) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; fig 8
In order to report on two cases of classic and desmoplastic medulloblastoma and the characterization of two new cell lines, Invitrogen ACTA2 antibody (Neomarkers, ACTN05) was used in western blot on human samples (fig 8). Neuropathology (2009) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; human; fig 4
In order to ascertain the role of epithelial cadherin in gamete interaction, Invitrogen ACTA2 antibody (Neomarkers, ACTN05) was used in western blot on human samples (fig 4). Mol Hum Reprod (2008) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry; human
  • immunohistochemistry; pig; fig 3
In order to investigate the effect of PEGDA hydrogel on the production of extracellular matrix from vocal fold fibroblasts, Invitrogen ACTA2 antibody (LabVision, 1A4) was used in immunohistochemistry on human samples and in immunohistochemistry on pig samples (fig 3). Acta Biomater (2008) ncbi
mouse monoclonal (1A4 (asm-1))
  • immunohistochemistry; pig; fig 3
In order to investigate the effect of PEGDA hydrogel on the production of extracellular matrix from vocal fold fibroblasts, Invitrogen ACTA2 antibody (LabVision, 1A4) was used in immunohistochemistry on pig samples (fig 3). Acta Biomater (2008) ncbi
mouse monoclonal (ACTN05 (C4))
  • western blot; rat; 1:1000
  • western blot; human; 1:1000
In order to compare hippocampi from temporal lobe epilepsy patients with those from non-epileptic patients, Invitrogen ACTA2 antibody (LabVision, ACTN05) was used in western blot on rat samples at 1:1000 and in western blot on human samples at 1:1000. Brain (2007) ncbi
mouse monoclonal (1A4 (asm-1))
  • immunohistochemistry - paraffin section; mouse; 34 ng/ml
In order to report that disruption of the mouse Par3 gene results in midgestational embryonic lethality with defective epicardial development, Invitrogen ACTA2 antibody (Zymed, 1A4) was used in immunohistochemistry - paraffin section on mouse samples at 34 ng/ml. Development (2006) ncbi
mouse monoclonal (1A4)
  • immunohistochemistry - paraffin section; mouse; 34 ng/ml
In order to report that disruption of the mouse Par3 gene results in midgestational embryonic lethality with defective epicardial development, Invitrogen ACTA2 antibody (Zymed, 1A4) was used in immunohistochemistry - paraffin section on mouse samples at 34 ng/ml. Development (2006) ncbi
Abcam
rabbit polyclonal
  • western blot; human
Abcam ACTA2 antibody (Abcam, ab15734) was used in western blot on human samples . PLoS ONE (2014) ncbi
Articles Reviewed
  1. Yin J, Wang Y, Chang J, Li B, Zhang J, Liu Y, et al. Apelin inhibited epithelial-mesenchymal transition of podocytes in diabetic mice through downregulating immunoproteasome subunits β5i. Cell Death Dis. 2018;9:1031 pubmed publisher
  2. Lino Cardenas C, Kessinger C, Cheng Y, MacDonald C, Macgillivray T, Ghoshhajra B, et al. An HDAC9-MALAT1-BRG1 complex mediates smooth muscle dysfunction in thoracic aortic aneurysm. Nat Commun. 2018;9:1009 pubmed publisher
  3. Xie X, Almuzzaini B, Drou N, Kremb S, Yousif A, Farrants A, et al. β-Actin-dependent global chromatin organization and gene expression programs control cellular identity. FASEB J. 2018;32:1296-1314 pubmed publisher
  4. Aguado L, Schmid S, May J, Sabin L, Panis M, Blanco Melo D, et al. RNase III nucleases from diverse kingdoms serve as antiviral effectors. Nature. 2017;547:114-117 pubmed publisher
  5. Garcia Hernandez M, Uribe Uribe N, Espinosa González R, Kast W, Khader S, Rangel Moreno J. A Unique Cellular and Molecular Microenvironment Is Present in Tertiary Lymphoid Organs of Patients with Spontaneous Prostate Cancer Regression. Front Immunol. 2017;8:563 pubmed publisher
  6. Pinnock C, Xu Z, Lam M. Scaling of Engineered Vascular Grafts Using 3D Printed Guides and the Ring Stacking Method. J Vis Exp. 2017;: pubmed publisher
  7. Moradi M, Sivadasan R, Saal L, Lüningschrör P, Dombert B, Rathod R, et al. Differential roles of α-, β-, and γ-actin in axon growth and collateral branch formation in motoneurons. J Cell Biol. 2017;216:793-814 pubmed publisher
  8. Weisshaar N, Welsch H, Guerra Moreno A, Hanna J. Phospholipase Lpl1 links lipid droplet function with quality control protein degradation. Mol Biol Cell. 2017;28:716-725 pubmed publisher
  9. Kimura M, Hashimoto N, Kusunose M, Aoyama D, Sakamoto K, Miyazaki S, et al. Exogenous induction of unphosphorylated PTEN reduces TGFβ-induced extracellular matrix expressions in lung fibroblasts. Wound Repair Regen. 2017;25:86-97 pubmed publisher
  10. Mayrhofer M, Gourain V, Reischl M, Affaticati P, Jenett A, Joly J, et al. A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth. Dis Model Mech. 2017;10:15-28 pubmed publisher
  11. Dezso K, Rókusz A, Bugyik E, Szücs A, Szuák A, Dorogi B, et al. Human liver regeneration in advanced cirrhosis is organized by the portal tree. J Hepatol. 2017;66:778-786 pubmed publisher
  12. Chen Z, Tang C, Zhu Y, Xie M, He D, Pan Q, et al. TrpC5 regulates differentiation through the Ca2+/Wnt5a signalling pathway in colorectal cancer. Clin Sci (Lond). 2017;131:227-237 pubmed publisher
  13. Matos M, Lapyckyj L, Rosso M, Besso M, Mencucci M, Briggiler C, et al. Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events. J Cell Physiol. 2017;232:1368-1386 pubmed publisher
  14. Suzuki Y, Katagiri H, Wang T, Kakisaka K, Kume K, Nishizuka S, et al. Ductular reactions in the liver regeneration process with local inflammation after physical partial hepatectomy. Lab Invest. 2016;96:1211-1222 pubmed publisher
  15. Sousa A, Rei M, Freitas R, Ricardo S, Caffrey T, David L, et al. Effect of MUC1/?-catenin interaction on the tumorigenic capacity of pancreatic CD133+ cells. Oncol Lett. 2016;12:1811-1817 pubmed
  16. Nazari B, Rice L, Stifano G, Barron A, Wang Y, Korndorf T, et al. Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90. Am J Pathol. 2016;186:2650-64 pubmed publisher
  17. Das S, Rehman I, Ghosh A, Sengupta S, Majumdar P, Jana B, et al. Poly(ADP-ribose) polymers regulate DNA topoisomerase I (Top1) nuclear dynamics and camptothecin sensitivity in living cells. Nucleic Acids Res. 2016;44:8363-75 pubmed publisher
  18. Passalacqua K, Charbonneau M, Donato N, Showalter H, Sun D, Wen B, et al. Anti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens. Antimicrob Agents Chemother. 2016;60:4183-96 pubmed publisher
  19. Kruzliak P, Hare D, Sabaka P, Delev D, Gaspar L, Rodrigo L, et al. Evidence for CD34/SMA positive cells in the left main coronary artery in atherogenesis. Acta Histochem. 2016;118:413-7 pubmed publisher
  20. Walia M, Ho P, Taylor S, Ng A, Gupte A, Chalk A, et al. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance. elife. 2016;5: pubmed publisher
  21. Strickland S, Vande Pol S. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC. J Virol. 2016;90:5611-5621 pubmed publisher
  22. Bach F, Zhang Y, Miranda Bedate A, Verdonschot L, Bergknut N, Creemers L, et al. Increased caveolin-1 in intervertebral disc degeneration facilitates repair. Arthritis Res Ther. 2016;18:59 pubmed publisher
  23. Shah D, Ali M, Pasha Z, Jaboori A, Jassim S, Jain S, et al. Histatin-1 Expression in Human Lacrimal Epithelium. PLoS ONE. 2016;11:e0148018 pubmed publisher
  24. Zhang W, Pelicano H, Yin R, Zeng J, Wen T, Ding L, et al. Effective elimination of chronic lymphocytic leukemia cells in the stromal microenvironment by a novel drug combination strategy using redox-mediated mechanisms. Mol Med Rep. 2015;12:7374-88 pubmed publisher
  25. Kleinhenz J, Murphy T, Pokutta Paskaleva A, Gleason R, Lyle A, Taylor W, et al. Smooth Muscle-Targeted Overexpression of Peroxisome Proliferator Activated Receptor-γ Disrupts Vascular Wall Structure and Function. PLoS ONE. 2015;10:e0139756 pubmed publisher
  26. Ertoy Baydar D, Kosemehmetoglu K, Aydin O, Bridge J, Buyukeren B, Aki F. Primary sclerosing epithelioid fibrosarcoma of kidney with variant histomorphologic features: report of 2 cases and review of the literature. Diagn Pathol. 2015;10:186 pubmed publisher
  27. Inoue O, Hokamura K, Shirai T, Osada M, Tsukiji N, Hatakeyama K, et al. Vascular Smooth Muscle Cells Stimulate Platelets and Facilitate Thrombus Formation through Platelet CLEC-2: Implications in Atherothrombosis. PLoS ONE. 2015;10:e0139357 pubmed publisher
  28. Kawaguchi T, Tsukiyama T, Kimura K, Matsuyama S, Minami N, Yamada M, et al. Generation of Naïve Bovine Induced Pluripotent Stem Cells Using PiggyBac Transposition of Doxycycline-Inducible Transcription Factors. PLoS ONE. 2015;10:e0135403 pubmed publisher
  29. Koren S, Reavie L, Couto J, De Silva D, Stadler M, Roloff T, et al. PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours. Nature. 2015;525:114-8 pubmed publisher
  30. Morancho B, Martínez Barriocanal Ã, Villanueva J, Arribas J. Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence. Breast Cancer Res. 2015;17:106 pubmed publisher
  31. Xie X, Hsu F, Gao X, Xu W, Ni J, Xing Y, et al. CDK8-Cyclin C Mediates Nutritional Regulation of Developmental Transitions through the Ecdysone Receptor in Drosophila. PLoS Biol. 2015;13:e1002207 pubmed publisher
  32. Lee J, Kim H, Han J, Kim Y, Son C. Anti-fatigue effect of Myelophil in a chronic forced exercise mouse model. Eur J Pharmacol. 2015;764:100-8 pubmed publisher
  33. Lee W, Shen S, Shih Y, Chou C, Tseng J, Chin S, et al. Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts. J Transl Med. 2015;13:191 pubmed publisher
  34. Hashem H, Abd El Haleem M, Abass M. Epithelial and stromal alterations in prostate after cypermethrin administration in adult albino rats (histological and biochemical study). Tissue Cell. 2015;47:366-72 pubmed publisher
  35. Zhao H, Agazie Y. Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment. BMC Cancer. 2015;15:109 pubmed publisher
  36. Hong S, Lee J, Lee J, Lee H, Kim H, Lee S, et al. The traditional drug Gongjin-Dan ameliorates chronic fatigue in a forced-stress mouse exercise model. J Ethnopharmacol. 2015;168:268-78 pubmed publisher
  37. Bergamo P, Palmieri G, Cocca E, Ferrandino I, Gogliettino M, Monaco A, et al. Adaptive response activated by dietary cis9, trans11 conjugated linoleic acid prevents distinct signs of gliadin-induced enteropathy in mice. Eur J Nutr. 2016;55:729-740 pubmed publisher
  38. Fang J, Zhou H, Zhang C, Shang L, Zhang L, Xu J, et al. A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner. Hepatology. 2015;62:452-65 pubmed publisher
  39. Yu T, Wang X, Zhao R, Zheng J, Li L, Ma W, et al. Beneficial effects of cannabinoid receptor type 2 (CB2R) in injured skeletal muscle post-contusion. Histol Histopathol. 2015;30:737-49 pubmed publisher
  40. Goossens S, Radaelli E, Blanchet O, Durinck K, Van der Meulen J, Peirs S, et al. ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling. Nat Commun. 2015;6:5794 pubmed publisher
  41. Izzo F, Mercogliano F, Venturutti L, Tkach M, Inurrigarro G, Schillaci R, et al. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth. Breast Cancer Res. 2014;16:491 pubmed publisher
  42. Roufayel R, Johnston D, Mosser D. The elimination of miR-23a in heat-stressed cells promotes NOXA-induced cell death and is prevented by HSP70. Cell Death Dis. 2014;5:e1546 pubmed publisher
  43. Fukuda M, Aoki T, Manabe T, Maekawa A, Shirakawa T, Kataoka H, et al. Exacerbation of intracranial aneurysm and aortic dissection in hypertensive rat treated with the prostaglandin F-receptor antagonist AS604872. J Pharmacol Sci. 2014;126:230-42 pubmed
  44. Gurzu S, Ciortea D, Tamasi A, Golea M, Bodi A, Sahlean D, et al. The immunohistochemical profile of granular cell (Abrikossoff) tumor suggests an endomesenchymal origin. Arch Dermatol Res. 2015;307:151-7 pubmed publisher
  45. Naylor A, McGettrick H, Maynard W, May P, Barone F, Croft A, et al. A differential role for CD248 (Endosialin) in PDGF-mediated skeletal muscle angiogenesis. PLoS ONE. 2014;9:e107146 pubmed publisher
  46. Ostapoff K, Cenik B, Wang M, Ye R, Xu X, Nugent D, et al. Neutralizing murine TGF?R2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis. Cancer Res. 2014;74:4996-5007 pubmed publisher
  47. Zheng Y, Hsu F, Xu W, Xie X, Ren X, Gao X, et al. A developmental genetic analysis of the lysine demethylase KDM2 mutations in Drosophila melanogaster. Mech Dev. 2014;133:36-53 pubmed publisher
  48. Gracanin A, Timmermans Sprang E, van Wolferen M, Rao N, Grizelj J, Vince S, et al. Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expression. PLoS ONE. 2014;9:e98698 pubmed publisher
  49. Hu B, Song J, Qu H, Bi C, Huang X, Liu X, et al. Mechanical stretch suppresses microRNA-145 expression by activating extracellular signal-regulated kinase 1/2 and upregulating angiotensin-converting enzyme to alter vascular smooth muscle cell phenotype. PLoS ONE. 2014;9:e96338 pubmed publisher
  50. Yuan B, Wan P, Chu D, Nie J, Cao Y, Luo W, et al. A cardiomyocyte-specific Wdr1 knockout demonstrates essential functional roles for actin disassembly during myocardial growth and maintenance in mice. Am J Pathol. 2014;184:1967-80 pubmed publisher
  51. Helm O, Mennrich R, Petrick D, Goebel L, Freitag Wolf S, Roder C, et al. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma. PLoS ONE. 2014;9:e94357 pubmed publisher
  52. Bach F, Rutten K, Hendriks K, Riemers F, Cornelissen P, de Bruin A, et al. The paracrine feedback loop between vitamin D? (1,25(OH)?D?) and PTHrP in prehypertrophic chondrocytes. J Cell Physiol. 2014;229:1999-2014 pubmed publisher
  53. Bronner D, O Riordan M, He Y. Caspase-2 mediates a Brucella abortus RB51-induced hybrid cell death having features of apoptosis and pyroptosis. Front Cell Infect Microbiol. 2013;3:83 pubmed publisher
  54. Hasty P, Livi C, Dodds S, Jones D, Strong R, Javors M, et al. eRapa restores a normal life span in a FAP mouse model. Cancer Prev Res (Phila). 2014;7:169-78 pubmed publisher
  55. Lee P, Yau D, Lau P, Chan J. Plexiform fibromyxoma (plexiform angiomyxoid myofibroblastic tumor) of stomach: an unusual presentation as a fistulating abscess. Int J Surg Pathol. 2014;22:286-90 pubmed publisher
  56. Kuroda Y, Wakao S, Kitada M, Murakami T, Nojima M, Dezawa M. Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells. Nat Protoc. 2013;8:1391-415 pubmed publisher
  57. Gopinath C, Ponsaerts P, Fransen E, Boeykens N, Pauwels P, Wyndaele J. Smooth muscle cell transplantation improves bladder contractile function in streptozocin-induced diabetic rats. Cytotherapy. 2013;15:869-78 pubmed publisher
  58. Syu L, El Zaatari M, Eaton K, Liu Z, Tetarbe M, Keeley T, et al. Transgenic expression of interferon-? in mouse stomach leads to inflammation, metaplasia, and dysplasia. Am J Pathol. 2012;181:2114-25 pubmed publisher
  59. Meyer D, Brinkhaus H, Müller U, Muller M, Cardiff R, Bentires Alj M. Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors. Cancer Res. 2011;71:4344-51 pubmed publisher
  60. Baydar D, Kulac I, Gurel B, De Marzo A. A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis. Int J Surg Pathol. 2011;19:131-6 pubmed publisher
  61. Tai C, Shen S, Lee W, Liao C, Deng W, Chiou H, et al. Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells. Exp Cell Res. 2010;316:2969-81 pubmed publisher
  62. Polo M, Arnoni M, Riggio M, Wargon V, Lanari C, Novaro V. Responsiveness to PI3K and MEK inhibitors in breast cancer. Use of a 3D culture system to study pathways related to hormone independence in mice. PLoS ONE. 2010;5:e10786 pubmed publisher
  63. Holthouse D, Dallas P, Ford J, Fabian V, Murch A, Watson M, et al. Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines. Neuropathology. 2009;29:398-409 pubmed publisher
  64. Marín Briggiler C, Veiga M, Matos M, Echeverría M, Furlong L, Vazquez Levin M. Expression of epithelial cadherin in the human male reproductive tract and gametes and evidence of its participation in fertilization. Mol Hum Reprod. 2008;14:561-71 pubmed publisher
  65. Liao H, Munoz Pinto D, Qu X, Hou Y, Grunlan M, Hahn M. Influence of hydrogel mechanical properties and mesh size on vocal fold fibroblast extracellular matrix production and phenotype. Acta Biomater. 2008;4:1161-71 pubmed publisher
  66. Rigau V, Morin M, Rousset M, de Bock F, Lebrun A, Coubes P, et al. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain. 2007;130:1942-56 pubmed
  67. Hirose T, Karasawa M, Sugitani Y, Fujisawa M, Akimoto K, Ohno S, et al. PAR3 is essential for cyst-mediated epicardial development by establishing apical cortical domains. Development. 2006;133:1389-98 pubmed